Your Source for Venture Capital and Private Equity Financings

Sherlock Biosciences Scores $80M in Series B

2022-03-10
BOSTON, MA, Sherlock Biosciences, a company engineering biology, has raised $80 million in a Series B financing led by Novalis LifeSciences.
BOSTON, MA, Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, has raised $80 million in a Series B financing.

The round was led by Novalis LifeSciences and included new investors Illumina Ventures, Albany Capital and Catalio Capital Management, among others. They joined Northpond Ventures, Good Ventures, and other existing investors, bringing $111 million in total funding raised to date.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors


Featured Reading